Swiss Life Sciences Stock News

On October 30, 2025, SIG Group AG announced its earnings guidance for 2026, projecting revenue growth of 0-2% at constant currency and resin, and confirmed plans to reinstate its dividend with a 30%-50% payout ratio for the year ending December 2026 following a dividend pause in 2025. This cautious outlook, coupled with the planned return to dividend payments, provides shareholders with greater clarity on expected performance and capital return policy amid ongoing subdued market...

Barry Callebaut (SWX:BARN) released its full-year earnings, revealing sales climbed to CHF 14.8 billion, up from the previous year. However, net income dipped slightly. Investors are examining what these numbers mean for future growth. See our latest analysis for Barry Callebaut. Barry Callebaut’s latest earnings drop came alongside a surge in its share price, with a standout 20.1% gain over the past week and 25.5% return in the last three months. This hints at renewed optimism for the...

Novartis (SWX:NOVN) delivered a one-two punch this week by reporting stronger earnings and unveiling new data from its Phase III ianalumab studies in Sjogren's disease at a top rheumatology conference. Both updates are attracting investor attention. See our latest analysis for Novartis. After a steady climb most of the year, Novartis shares are showing renewed momentum, with a 16.92% year-to-date share price return and a 1.84% bump following this week’s headline-grabbing earnings and...

Sensirion recently held a groundbreaking ceremony for a new 11,000 m² high-tech production facility in Stafa, Switzerland, designed to address capacity constraints and support future advances in cleanroom manufacturing for the semiconductor industry. By also launching the versatile SGM5304 gas meter module and securing additional land for offices, the company is showcasing both long-term operational commitment and innovation in smart metering solutions to meet the evolving needs of global...

Adecco Group AG recently released its third-quarter 2025 results, reporting sales of €5.78 billion and net income of €89 million, while also announcing that Coram Williams will step down as CFO to be succeeded by Valentina Ficaio in January 2026. The leadership change comes as Adecco faces flat sales growth but lower profits, positioning the company for a new phase in financial management amid evolving market conditions. We'll consider how the appointment of a new CFO, alongside recent...

Bachem Holding AG announced that Anne-Kathrin Stoller will become its new CEO on January 1, 2026, following the departure of Thomas Meier after over three decades with the company. Stoller's extensive experience across multiple leadership roles at Bachem, including her recent tenure as Chief Operating Officer Americas, positions her as a leader with deep company and industry knowledge. With Stoller set to bring her operational expertise to the CEO position, we'll explore how this leadership...

Julius Bär Gruppe recently received regulatory approval to open a dedicated branch of Bank Julius Baer Europe Ltd. in Lisbon, Portugal, with the new office set to begin serving ultra-high and high-net-worth clients in early 2026. This move underscores Julius Bär's ongoing commitment to expanding its European footprint and supporting clients with an established, locally-based team while maintaining leadership continuity. We'll explore how establishing a regulated presence in Lisbon could...

Galderma Group (SWX:GALD) received FDA approval for Restylane Lyft with Lidocaine, now cleared for chin augmentation in adults. Backed by pivotal trial data, this move further broadens Restylane Lyft’s indications in the US market. See our latest analysis for Galderma Group. Galderma Group’s FDA win added fresh momentum to its already impressive run this year. Recent gains have kept investor attention squarely on the company’s growth story. The stock’s 47.6% year-to-date share price return...

Temenos (SWX:TEMN) has drawn fresh attention after a shift in its recent stock movement. Investors are closely watching how the company’s performance metrics and market sentiment could shape its outlook in the coming months. See our latest analysis for Temenos. Temenos has seen renewed momentum lately, with the share price climbing 14% over the past month and posting a 15% year-to-date gain. While its one-year total shareholder return stands at an impressive 27%, it is still working to...

With its stock down 2.2% over the past three months, it is easy to disregard Lonza Group (VTX:LONN). It is possible...

With a price-to-earnings (or "P/E") ratio of 16.9x SFS Group AG ( VTX:SFSN ) may be sending bullish signals at the...

Nestlé (SWX:NESN) shares have been attracting renewed interest lately, due to a steady uptick over the past month. Investors are weighing these recent gains against the company’s longer-term performance and business fundamentals. See our latest analysis for Nestlé. This recent rally builds on a positive trend for Nestlé, as the stock has posted a 4.6% one-month share price return and is up 5.9% year-to-date. Despite this momentum, the one-year total shareholder return remains modest at 3.7%,...

When close to half the companies in Switzerland have price-to-earnings ratios (or "P/E's") below 19x, you may consider...

As European markets face pressures from concerns over artificial intelligence stock valuations and major indices like the STOXX Europe 600 experience declines, investors are increasingly looking for stability in dividend stocks. In uncertain times, a good dividend stock is often characterized by its ability to provide consistent yields and financial resilience, making them attractive options for those seeking reliable income amidst fluctuating market conditions.

BELIMO Holding AG's ( VTX:BEAN ) price-to-earnings (or "P/E") ratio of 56.6x might make it look like a strong sell...

Key Insights Siegfried Holding's estimated fair value is CHF73.83 based on 2 Stage Free Cash Flow to Equity Current...

Zurich Insurance Group recently reported a Swiss Solvency Test ratio of 257% as of September 30 and achieved record gross written premium growth, with an 8% increase year-over-year in Property & Casualty and an 11% rise in the Life business, both driven by higher product sales and distribution partnerships. An exceptionally strong capital position and robust premium performance across core divisions reflect strengthened operational momentum for Zurich Insurance Group. We'll examine how...

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...

The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...

Investors in Adecco Group AG ( VTX:ADEN ) had a good week, as its shares rose 7.9% to close at CHF24.20 following the...

Key Insights Significant insider control over Xlife Sciences implies vested interests in company growth A total of 4...

Even though Novartis AG's ( VTX:NOVN ) recent earnings release was robust, the market didn't seem to notice. Investors...

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...

When close to half the companies in Switzerland have price-to-earnings ratios (or "P/E's") below 19x, you may consider...